00874.HK
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 12.86
+2.14%Year over year
Reported trailing growth
- Revenue
- +0.4%
- EBITDA
- -33.3%
- EBIT
- -33.6%
- EPS
- -27.3%
- Free cash flow
- +10.8%
- Operating cash flow
- +245.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +3.1%
- EBITDA
- -14.0%
- EBIT
- -10.6%
- Net income
- -9.1%
- EPS
- -9.1%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026